首页>Clinical lymphoma, myeloma & leukemia>Complete remission achieved with single agent CNTO 328, an anti-IL-6 monoclonal antibody, in relapsed and refractory myeloma
Complete remission achieved with single agent CNTO 328, an anti-IL-6 monoclonal antibody, in relapsed and refractory myeloma
作者单位：Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Organization, Jerusalem 91120[1]Department of Medicine, Division of Hematology/Oncology, Mt Sinai School of Medicine, New York, NY[2]
换一批
